A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS

References

• Brooks BR. Natural history of ALS: symptoms, strength, pulmonary function, and disability. Neurology. 1996:47: S71–81.
   PubMed Web of Science ®Google Scholar
• Okamoto K, Kihira T, Kondo T, Kobashi G, Washio M, Sasaki S, . Nutritional status and risk of amyotrophic lateral sclerosis in Japan. Amyotroph Lateral Scler. 2007;8:300–4.
   PubMed Web of Science ®Google Scholar
• Abel EL. Football increases the risk for Lou Gehrig's disease, amyotrophic lateral sclerosis. Percept Mot Skills. 2007;104:1251–4.
   PubMed Web of Science ®Google Scholar
• Chiò A, Benzi G, Dossena M, Mutani R, Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain. 2005; 128:472–6.
   PubMed Web of Science ®Google Scholar
• Scarmeas N, Shih T, Stern Y, Ottman R, Rowland LP. Premorbid weight, body mass, and university athletics in ALS. Neurology. 2002;59:773–5.
   PubMed Web of Science ®Google Scholar
• Longstreth WT, McGuire V, Koepsell TD, Wang Y, van Belle G. Risk of amyotrophic lateral sclerosis and history of physical activity: a population based case-control study. Arch Neurol. 1998;55:201–6.
   PubMedGoogle Scholar
• Veldink JH, Kalmijn S, Groeneveld GJ, Titulaer MJ, Wokke JH, van den Berg LH. Physical activity and the association with sporadic ALS. Neurology. 2005;64:241–5.
   PubMed Web of Science ®Google Scholar
• Desport JC, Preux PM, Truong CT, Courat L, Vallat JM, Couratier P. Nutritional assessment and survival in ALS patients. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:91–6.
   PubMed Web of Science ®Google Scholar
• Desport JC, Torny F, Lacoste M, Preux PM, Couratier P. Hypermetabolism in ALS: correlations with clinical and paraclinical parameters. Neurodegener Dis. 2005;2:202–7.
   PubMed Web of Science ®Google Scholar
• Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, . Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol. 2009;256:1236–42.
   PubMed Web of Science ®Google Scholar
• Dupuis L, Corcia P, Fergani A, Gonzalez de Aguilar JL, Bonnefont-Rousselot D, Bittar R, . Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004–9.
   PubMed Web of Science ®Google Scholar
• Jawaid A, Salamone AR, Strutt AM, Murthy SB, Wheaton M, Simpson E, . ALS disease onset may occur later in patients with premorbid diabetes mellitus. Eur J Neur. 2010;17:733–39
   Google Scholar
• Pessolano FA, Súarez AA, Monteiro SG, Mesa L, Dubrovsky A, Roncoroni AJ, . Nutritional assessment of patients with neuromuscular diseases. Am J Phys Med Rehabil. 2003;82:182–5.
   PubMed Web of Science ®Google Scholar
• Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial ‘Clinical limits of amyotrophic lateral sclerosis’ workshop contributors. J Neurol Sci. 1994;124:96–107.
   PubMed Web of Science ®Google Scholar
• World Health Organization Global Database on Body Mass Index. Available online: http://apps.who.int/bmi/index.jsp?introPage=intro_3.html. Accessed online: July 8, 2009.
   Google Scholar
• Appel V, Stewart S, Smith G, Appel S. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol. 1987;22:328–33.
   PubMed Web of Science ®Google Scholar
• Voustianiouk A, Seidel G, Panchal J, Sivak M, Czaplinski A, Yen A, . ALSFRS and Appel ALS scores: discordance with disease progression. Muscle Nerve. 2008;37:668–72.
   PubMed Web of Science ®Google Scholar
• Qureshi MM, Hayden D, Urbinelli L, Ferrante K, Newhall K, Myers D, . Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS). Amyotroph Lateral Scler. 2006;7:173–82.
   PubMed Web of Science ®Google Scholar
• del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population based study. Neurology. 2003;60:813–9.
   PubMed Web of Science ®Google Scholar
• Zetterberg H, Jacobsson J, Rosengren L, Blennow K, Andersen PM. Association of APOE with age at onset of sporadic amyotrophic lateral sclerosis. J Neurol Sci. 2008;273:67–9.
   PubMed Web of Science ®Google Scholar
• Li YJ, Pericak-Vance MA, Haines JL, Siddique N, McKenna-Yasek D, Hung WY, . Apolipoprotein E is associated with age at onset of amyotrophic lateral sclerosis. Neurogenetics. 2004;5:209–13.
   PubMed Web of Science ®Google Scholar
• Kasarskis EJ, Berryman S, van der Leest JG, Schneider AR, McClain CJ. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr. 1996;63:130–7.
   PubMed Web of Science ®Google Scholar
• Menzies FM, Ince PG, Shaw PJ. Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochem Int. 2002;40: 543–51.
   PubMed Web of Science ®Google Scholar
• Mattson MP, Cutler RG, Camandola S. Energy intake and amyotrophic lateral sclerosis. Neuromolecular Med. 2007;9:17–20.
   PubMed Web of Science ®Google Scholar
• Katona P, Katona-Apte J. The interaction between nutrition and infection. Clin Infect Dis. 2008;46:1582–8.
   PubMed Web of Science ®Google Scholar
• Zoccolella S, Beghi E, Palagano G, Fraddosio A, Guerra V, Samarelli V, . Riluzole and amyotrophic lateral sclerosis survival: a population based study in southern Italy. Eur J Neurol. 2007;14:262–8.
   PubMed Web of Science ®Google Scholar
• Dupuis L, Oudart H, René F, Gonzalez de Aguilar JL, Loeffler JP. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A. 2004;101:11159–64.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Lange DJ, Voustianiouk A, MacGrogan D, Ho L, Suh J, . A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis. BMC Neurosci. 2006;7:29.
   PubMed Web of Science ®Google Scholar
• Czaplinski A, Yen AA, Appel SH. Amyotrophic lateral sclerosis: early predictors of prolonged survival. J Neurol. 2006; 253:1428–36.
   PubMed Web of Science ®Google Scholar
• del Aguila MA, Longstreth WT Jr, McGuire V, Koepsell TD, van Belle G. Prognosis in amyotrophic lateral sclerosis: a population based study. Neurology. 2003;60:813–9.
   PubMed Web of Science ®Google Scholar